Correlation Between Cue Biopharma and Elicio Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Elicio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Elicio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Elicio Therapeutics, you can compare the effects of market volatilities on Cue Biopharma and Elicio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Elicio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Elicio Therapeutics.
Diversification Opportunities for Cue Biopharma and Elicio Therapeutics
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Cue and Elicio is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Elicio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elicio Therapeutics and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Elicio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elicio Therapeutics has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Elicio Therapeutics go up and down completely randomly.
Pair Corralation between Cue Biopharma and Elicio Therapeutics
Considering the 90-day investment horizon Cue Biopharma is expected to generate 2.48 times more return on investment than Elicio Therapeutics. However, Cue Biopharma is 2.48 times more volatile than Elicio Therapeutics. It trades about 0.13 of its potential returns per unit of risk. Elicio Therapeutics is currently generating about 0.11 per unit of risk. If you would invest 66.00 in Cue Biopharma on September 2, 2024 and sell it today you would earn a total of 56.00 from holding Cue Biopharma or generate 84.85% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cue Biopharma vs. Elicio Therapeutics
Performance |
| Timeline |
| Cue Biopharma |
| Elicio Therapeutics |
Cue Biopharma and Elicio Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and Elicio Therapeutics
The main advantage of trading using opposite Cue Biopharma and Elicio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Elicio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elicio Therapeutics will offset losses from the drop in Elicio Therapeutics' long position.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
| Elicio Therapeutics vs. Lion One Metals | Elicio Therapeutics vs. Patterson UTI Energy | Elicio Therapeutics vs. Perseus Mining Limited | Elicio Therapeutics vs. Integrated Drilling Equipment |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |